BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2033871)

  • 1. [Genetic engineering of human insulin].
    Shibasaki Y; Kanazawa Y
    Nihon Rinsho; 1991 Feb; 49 Suppl():737-43. PubMed ID: 2033871
    [No Abstract]   [Full Text] [Related]  

  • 2. [Construction of a family of artificial genes of human insulin].
    Efimov VA; Buriakova AA; Pashkova IN; Polushin NN; Chakhmakhcheva OG
    Bioorg Khim; 1989 Aug; 15(8):1070-7. PubMed ID: 2686651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Classification and development stage of human insulin preparations].
    Ishii J; Negishi K
    Nihon Rinsho; 1989 Nov; 47(11):2539-46. PubMed ID: 2689688
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biological safety investigations of the production of human insulin by genetically engineered E. coli K-12 cells. 1. Survival capacity of the production strain in the digestive tract of Göttinger miniature swine].
    Mieschendahl M; Finkernagel K; Hunke C; Spranz E
    Zentralbl Hyg Umweltmed; 1992 Dec; 193(4):342-9. PubMed ID: 1290564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bacterial synthesis of human insulin -- achievement of genetic engineering].
    Germaniuk IaL
    Vrach Delo; 1981 Nov; (11):38-40. PubMed ID: 7043895
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on genetic engineering of human insulin-purification and characterization of human proinsulin and insulin].
    Guo LH; Zhou MY; Shen MH; Wang EB; Liu JF; Yu YJ
    Shi Yan Sheng Wu Xue Bao; 1992 Jun; 25(2):157-63. PubMed ID: 1414126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione and its derivatives: produced by recombinant Escherichia coli and Saccharomyces cerevisiae.
    Murata K
    Bioprocess Technol; 1994; 19():159-83. PubMed ID: 7764757
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biological safety investigation of the production of human insulin using genetically altered E. coli K-12 cells. 2. Plasmid transfer by mobilization and cointegrate formation under environmental conditions].
    Mieschendahl M; Finkernagel K; Schaffrath S
    Zentralbl Hyg Umweltmed; 1993 Feb; 193(5):481-93. PubMed ID: 8476500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of human biosynthetic insulin of saccharomyces cerevisiae origin.
    Rais N; Churi C; Kapur A
    J Assoc Physicians India; 1993 Jun; 41(6):401-2. PubMed ID: 8005994
    [No Abstract]   [Full Text] [Related]  

  • 10. Overexpression for commercial production of recombinant human insulin as A-chain and B-chain fusion protein in Escherichia coli through genetically engineered plasmids.
    Chakraborty C
    Indian J Pathol Microbiol; 2004 Oct; 47(4):569-73. PubMed ID: 16295400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biosynthesis and isolation of a recombinant protein for producing genetically-engineered human proinsulin].
    Ivankin AN; Mitaleva SI; Nekliudov AD
    Prikl Biokhim Mikrobiol; 1998; 34(3):293-9. PubMed ID: 9644711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Production of hepatitis B vaccine by applying genetic engineering technology].
    Miyanohara A; Matsubara K
    Nihon Rinsho; 1983 May; 41(5):1120-34. PubMed ID: 6355559
    [No Abstract]   [Full Text] [Related]  

  • 13. Production of human insulin in an E. coli system with Met-Lys-human proinsulin as the expressed precursor.
    Chen JQ; Zhang HT; Hu MH; Tang JG
    Appl Biochem Biotechnol; 1995 Oct; 55(1):5-15. PubMed ID: 7486987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation of recombinant human insulin--study of downstream process].
    Yu R; Li X; Yang J; Wu W
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Oct; 21(5):805-8. PubMed ID: 15553863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biosynthesis of insulin: genetic, evolutionary, and pathophysiologic aspects.
    Steiner DF
    Harvey Lect; 1982-1983; 78():191-228. PubMed ID: 6765346
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental studies on somatic gene therapy for diabetes. I. Structuring of recombinant from human insulin gene and ammalian expression vector PRC/CMV].
    Xiao X; Wang H; Fang F; Sun Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Apr; 19(2):145-9. PubMed ID: 10453511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis cloning and expressions in E coli of human insulin A and B chain genes].
    Guo LH; Wang EB; Zhang XY; Zhu LH; Yu YJ; Wang YK; Luo GX; Zhou MY
    Shi Yan Sheng Wu Xue Bao; 1992 Sep; 25(3):283-8. PubMed ID: 1476017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human insulin. VIII. Isolation of fusion protein--S-sulfonate, biotechnological precursor of human insulin, from the biomass of transformed Escherichia coli cells.
    Tikhonov RV; Pechenov SE; Belacheu IA; Yakimov SA; Klyushnichenko VE; Boldireva EF; Korobko VG; Tunes H; Thiemann JE; Vilela L; Wulfson AN
    Protein Expr Purif; 2001 Feb; 21(1):176-82. PubMed ID: 11162404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and secretion of human atrial natriuretic peptide in Saccharomyces cerevisiae.
    Qin N; Wei N; Yao XH; Li YY
    Sci China B; 1991 Dec; 34(12):1478-84. PubMed ID: 1839353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protein engineering of human pancreatic secretory trypsin inhibitor (PSTI)].
    Teraoka H; Yoshida N
    Tanpakushitsu Kakusan Koso; 1990 Oct; 35(14):2654-64. PubMed ID: 2267344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.